Inoue, N., Kobayashi, K., Naganuma, M., Hirai, F., Ozawa, M., Arikan, D., . . . Hibi, T. (2017). Long-term safety and efficacy of adalimumab for intestinal Behçet's disease in the open label study following a phase 3 clinical trial. Intest Res.
استشهاد بنمط شيكاغوInoue, Nagamu, et al. "Long-term Safety and Efficacy of Adalimumab for Intestinal Behçet's Disease in the Open Label Study Following a Phase 3 Clinical Trial." Intest Res 2017.
MLA استشهادInoue, Nagamu, et al. "Long-term Safety and Efficacy of Adalimumab for Intestinal Behçet's Disease in the Open Label Study Following a Phase 3 Clinical Trial." Intest Res 2017.
تحذير: قد لا تكون هذه الاستشهادات دائما دقيقة بنسبة 100%.